Filing Details
- Accession Number:
- 0001214659-18-003059
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-04-26 18:00:30
- Reporting Period:
- 2018-03-09
- Accepted Time:
- 2018-04-26 18:00:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1576263 | Mirati Therapeutics Inc. | MRTX | Pharmaceutical Preparations (2834) | 462693615 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1599324 | Jamie Christensen | C/O Mirati Therapeutics, Inc. 9393 Towne Centre Drive, Ste 200 San Diego CA 92121 | Svp, Chief Scientific Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-03-09 | 7,000 | $17.41 | 9,877 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2018-03-09 | 7,500 | $21.51 | 17,377 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2018-03-09 | 7,500 | $24.99 | 24,877 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-03-09 | 22,000 | $33.00 | 2,877 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2018-03-09 | 7,000 | $0.00 | 7,000 | $17.41 |
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2018-03-09 | 7,500 | $0.00 | 7,500 | $21.51 |
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2018-03-09 | 7,500 | $0.00 | 7,500 | $24.99 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 18,936 | 2024-05-20 | No | 4 | M | Direct | |
| 15,000 | 2025-02-03 | No | 4 | M | Direct | |
| 45,000 | 2026-01-21 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2017.
- This transaction was executed in multiple trades at prices ranging from $33.00 to $33.005. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to
- 1/4th of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of the shares subject to the Option shall vest each month thereafter
Billionaire Hedge Funds
